@scottjo88508204 @KlendathuCap @MattBiotech The safety profile of iPSC NK is an issue and not convinced that $fate or anybody else has the solution . https://t.co/SsrATUYBCg
@PersimmonTI Not clear to me how UCSD and $fate researchers are addressing iPSC point mutations. Is the only way to have human trials that last for years? Has anyone looked at it here? @dhovekamp42 ? https://t.co/UAGmIgEFQK
RT @norionakatsuji: 積ん読してた論文を休日に読んだ(2/3)。iPS細胞におけるゲノム不安定性と臨床応用への問題点。理研等の研究者の総説。初期化の方法比較やどの段階で異常起きるかなど考察。"Genomic Instability of iPSCs:-" ht…
RT @norionakatsuji: 積ん読してた論文を休日に読んだ(2/3)。iPS細胞におけるゲノム不安定性と臨床応用への問題点。理研等の研究者の総説。初期化の方法比較やどの段階で異常起きるかなど考察。"Genomic Instability of iPSCs:-" ht…
積ん読してた論文を休日に読んだ(2/3)。iPS細胞におけるゲノム不安定性と臨床応用への問題点。理研等の研究者の総説。初期化の方法比較やどの段階で異常起きるかなど考察。"Genomic Instability of iPSCs:-" https://t.co/nUPDNgne9S
Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications https://t.co/wni2Vk2EhZ #Mutation #iPSCs